Infectious Diseases and Livelihoods

  • Fingani Annie Mphande


Agriculture has been the most common form of livelihood for rural communities in developing countries for centuries. Apart from providing a livelihood , rural communities find food and nutrients necessary for their survival and well-being from their farms. Agriculture also brings risks to health through infectious diseases. Poor health leads to reduction in productivity , where individuals are not able to carry out their livelihoods due to ill health . This could lead to reduction in income through excess expenditure on treatments, thereby inhibiting economic development of the affected communities. Infectious diseases have both direct and indirect impact on livelihoods . The direct impact includes poor health and loss of lives, which leads to partial and complete loss of livelihoods. Indirectly, infectious diseases lead to loss of income through poor performance of livelihoods as well as diversion of resources that could have been used to improve livelihood to seek medical treatment . Due to the effects of disease, individuals become marginalized, socially affecting their businesses and ways of earning a livelihood.


Infectious diseases Rural livelihood Quarantine Poverty Social welfare Haemorrhagic fever Economic hardship Measles Outbreak response immunization (ORI) HIV/AIDS HIV prevalence Ebola Antibiotic resistant bacteria Cholera 


  1. Abbot D, Pollard S (2004) Hardships and poverty in the pacific—strengthening poverty analysis and strategies in the pacific. Asia Development Bank, ManillaGoogle Scholar
  2. Almeida Da Silva PEA, Palomino JC (2011) Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs. J Antimicrob Chemother 66(7), 1417–30.
  3. Aylward B, Tangermann R (2011) The global polio eradication initiative: lessons learned and prospects for success. Vaccine, 29(SUPPL. 4):D80–D85. doi:
  4. Beare NAV, Lewallen S, Taylor TE, Molyneux ME (2011) Redefining cerebral malaria by including malaria retinopathy. Future Microbiol, 6(3):349–355. doi:
  5. Boscarino JA, Adams RE (2015) Assessing community reactions to Ebola virus disease and other disasters: using social psychological research to enhance public health and disaster communications. Int J Emerg Mental Health 17(1):234–238. doi:
  6. Brenzel L, Wolfson LJ, Fox-Rushby J, Miller M, Halsey NA (2006) Vaccine-preventable diseases. In: Jamison DT, Breman JG, Measham AR, Alleyne G., Claeson M, Evans DB, Musgrove P (eds) Disease control priorities in developing countries, 2nd edn. World Bank, Washington (DC)Google Scholar
  7. Cenciarelli O, Pietropaoli S, Malizia A, Carestia M, D’Amico F, Sassolini A, Gaudio P (2015) Ebola virus disease 2013–2014 outbreak in west Africa: an analysis of the epidemic spread and response. Int J Microbiol 769121. doi: (2015(Figure 1))
  8. Chadha SS, Bn S, Reddy K, Jaju J, Ph V, Rao S, Harries AD (2011) Operational challenges in diagnosing multi-drug resistant TB and initiating treatment in Andhra Pradesh, India. PLoS One, 6(11), 1–5. doi:
  9. Daniel O, Osman E (2011) Prevalence and risk factors associated with drug resistant TB in South West, Nigeria. Asian Pac J Trop Med 4(2):148–151. doi:
  10. Farmer PE (2013) Chronic infectious disease and the future of health care delivery. N Engl J Med 369(25):2424–2436. doi:
  11. Fürst T, Tschannen AB, Raso G, Acka CA, de Savigny D, Girardin O, Utzinger J (2010) Effect of an armed conflict on relative socioeconomic position of rural households: case study from western Côte d’Ivoire. Emerg Themes Epidemiol 7, 6. doi:
  12. Ganapathiraju PV, Morssink CB, Plumb J (2015) Endgame for polio eradication? Options for overcoming social and political factors in the progress to eradicating polio. Glob Public Health 10(4):463–473. doi:
  13. Genêt F, Théfenne L, Boyer F (1987) Post-polio syndrome. J Med Assoc Georgia 59(5), 428–430. doi:
  14. Gillespie S, Kadiyala S (2005) HIV/AIDS and food and nutrition security: from evidence to actionGoogle Scholar
  15. Goodson JL, Sosler S, Pasi O, Johnson T, Kobella M, Monono ME, Uzicanin A (2011) Impact of a measles outbreak response immunization campaign: Maroua, Cameroon, 2009. J Infect Dis 204(Supplement 1):S252–S259. doi:
  16. Hedt BL, Laufer MK, Cohen T (2011) Drug resistance surveillance in resource-poor settings: current methods and considerations for TB, HIV, and malaria. Am J Trop Med Hyg 84(2), 192–199. doi:
  17. Hoek KGP, Schaaf HS, van Pittius NCG, van Helden PD, Warren RM (2009) Resistance to pyrazinamide and ethambutol compromises MDR/XDR-TB treatment. S Afr Med J. doi:
  18. Kamadjeu R, Mahamud A, Webeck J, Baranyikwa MT, Chatterjee A, Bile YN, Mulugeta A (2014) Polio outbreak investigation and response in Somalia, 2013. J Infect Dis 210(Suppl 1):S181–186. doi:
  19. Lien G, Heymann DL (2013) The problems with polio: toward eradication. Infect Dis Ther 2(2), 167–74. doi:
  20. Malawi. (n.d.)Google Scholar
  21. Miller MA, Sentz JT (2006) Vaccine-preventable diseases. In: Jamison DT, Feachem RG, Makgoba MW, Bos ER, Baingana FK, Hofman KJ, Rogo KO (eds) Disease and mortality in Sub-Saharan Africa, 2nd edn. World Bank, Washington (DC)Google Scholar
  22. Milner DA, Vareta J, Valim C, Montgomery J, Daniels RF, Volkman SK, Wirth DF (2012) Human cerebral malaria and Plasmodium falciparum genotypes in Malawi. Malaria J 11(1):35. doi:
  23. Milner D, Factor R, Whitten R, Carr RA, Kamiza S, Pinkus G, Taylor T (2013) Pulmonary pathology in pediatric cerebral malaria. Hum Pathol 44(12), 2719–2726. doi:
  24. Minnery M, Contreras C, Pérez R, Solórzano N, Tintaya K, Jimenez J, Lecca L (2013) A cross sectional study of knowledge and attitudes towards tuberculosis amongst front-line tuberculosis personnel in high burden areas of Lima, Peru. PLoS One 8(9):e75698. doi:
  25. Montgomery J, Mphande FA, Berriman M, Pain A, Rogerson SJ, Taylor TE, Craig A (2007) Differential var gene expression in the organs of patients dying of falciparum malaria. Mol Microbiol 65(4), 959–67. doi:
  26. Mutangadura GB (2005) Gender, HIV/AIDS and rural livelihoods in Southern Africa: addressing the challenges. JENDA J Culture Afr Women Stud 7:1–19Google Scholar
  27. Nagaraja SB, Satyanarayana S, Chadha SS, Kalemane S, Jaju J, Achanta S, Singh SK (2011) How do patients who fail first-line tb treatment but who are not placed on an MDR-TB regimen fare in south india? PLoS One, 6(10), 1–6. doi:
  28. Owais A, Khowaja AR, Ali SA, Zaidi AKM (2013) Pakistan’s expanded programme on immunization: an overview in the context of polio eradication and strategies for improving coverage. Vaccine, 31(33):3313–3319. doi:
  29. Rahman BA, Wasfy MO, Maksoud MA, Hanna N, Dueger E, House B (2014) Multi-drug resistance and reduced susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates from the Middle East and Central Asia. New Microbes New Infect 2(4), 88–92. doi:
  30. Roberts L (2009) Polio: looking for a little luck. Science, 323(5915):702–705. doi:
  31. Roca-Feltrer A, Kwizombe CJ, Sanjoaquin MA, Sesay SSS, Faragher B, Harrison J, Heyderman RS (2012) Lack of decline in childhood Malaria, Malawi, 2001–2010. Emerg Infect Dis 18(2):272–278. doi:
  32. Shaw SJ, Huebner C, Armin J, Orzech K, Vivian J (2009) The role of culture in health literacy and chronic disease screening and management. J Immigr Minor Health 11(6):531–531. doi:
  33. Sniadack DH, Moscoso B, Aguilar R, Heath J, Bellini W, Chuy Chiu M (1999) Measles epidemiology and outbreak response immunization in a rural community in Peru. Bull World Health Organ 77(7):545–552PubMedPubMedCentralGoogle Scholar
  34. States U, Tb MDR, Partnership STB, Committee GL, Tb MDR (2006) Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs. Ann Pharmacother 40(5):1007–1008. doi:
  35. Tang S, Tan S, Yao L, Li F, Li L, Guo X, Huang J (2013) Risk factors for poor treatment outcomes in patients with MDR-TB and XDR-TB in China: retrospective multi-center investigation. PLoS One 8(12):1–8. doi:
  36. Tangermann RH, Hull HF, Jafari H, Nkowane B, Everts H, Aylward RB (2000) Eradication of poliomyelitis in countries affected by conflict. Bull World Health Organ 78(3):330–338PubMedPubMedCentralGoogle Scholar
  37. Taylor TE, Fu WJ, Carr RA, Whitten RO, Mueller JS, Fosiko NG, Mueller JG (2004) Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nat Med 10(2):143–5. doi:
  38. Unaids W (2009) AIDS epidemic update 2009. Joint united nations programme on HIVAIDS UNAIDS and World Health Organization WHO, 10(22.07.10), 100.
  39. Unnevehr L (2003) Costs and benefits of food safety regulation. OECD Papers, 3(7):9–51. Retrieved from
  40. Vernet G, Mary C, Altmann DM, Doumbo O, Morpeth S, Bhutta ZA, Klugman KP (2014) Surveillance for antimicrobial drug resistance in under-resourced countries. Emerg Infect Dis 20(3):434–441. doi:
  41. WHO (2010) Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. World Health Organization, Geneva. Retrieved from
  42. WHO (2012) Global report UNAIDS report on the global AIDS epidemic: 2012. UNAIDS, GenevaGoogle Scholar
  43. WHO|Circulating vaccine-derived poliovirus—Ukraine (n.d.)Google Scholar
  44. WHO|Measles (n.d.)Google Scholar
  45. WHO|One year into the Ebola epidemic: a deadly, tenacious and unforgiving virus (n.d.)Google Scholar

Copyright information

© Springer Science+Business Media Singapore 2016

Authors and Affiliations

  1. 1.Independent ConsultantMihama-ku, Chiba-shiJapan

Personalised recommendations